Form 4 for RMD ResMed|
Accepted 2023-11-15 00:00:00 ET · period of report 2023-11-13 · accession 0001127602-23-027461 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-15 | 2023-11-13 | RMD | BLAISE LUCILE | Pres, Sleep, RC Business | F - Tax | $143.60 | -135.35 | 10.3K | -1% | -$19.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2023-11-13 | F | D | 135.35 | $143.60 | 10,305 | D | — | — | (F2) Includes 85.032 shares of ResMed stock purchased on October 31, 2023, through the ResMed Employee Stock Purchase Plan. |